Skip to main content
← Transaction feed

Source-linked transaction record

Rep. James R. Langevin: reported sale of alexion Pharmaceuticals, Inc. (aLXN) on Jan 6, 2017

Rep. James R. Langevin disclosed that the filer sold alexion Pharmaceuticals, Inc. (aLXN) for the reported amount of $15,001 – $50,000. The filing identifies the account owner as filer.

What the filing reports

Account owner
Filer
Transaction
sale
Reported amount
$15,001 – $50,000
Transaction date
Jan 6, 2017
Notice date
Jan 6, 2017
Filing date
Jan 13, 2017
Filing timing
7 days to file
House document
20006551
Filing year
2017

Disclosures are reported transactions, not verified real-time portfolio holdings.

Continue researching

More disclosures from James R. Langevin

Open member history →
Relevant OurElectedNews.com reporting ↗